NOUVELLE PHARMACIE SERRIER : revenue, balance sheet and financial ratios

NOUVELLE PHARMACIE SERRIER is a French company founded 16 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTIGNY-LES-METZ (57950), this company of category PME shows in 2023 a revenue of 6.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - NOUVELLE PHARMACIE SERRIER (SIREN 519668883)
Indicator 2024 2023 2022 2021 2018 2017
Revenue N/C 6 625 638 € 11 209 140 € 11 682 026 € N/C N/C
Net income 23 203 € -278 223 € -114 585 € -2 072 178 € 23 086 € 40 544 €
EBITDA N/C 233 664 € 596 631 € -1 277 763 € N/C N/C
Net margin N/C -4.2% -1.0% -17.7% N/C N/C

Revenue and income statement

In 2024, NOUVELLE PHARMACIE SERRIER generates positive net income of 23 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 41 k€ -> 23 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

23 203 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 3152%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 3%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

3151.832%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

2.578%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

54.0%

Solvency indicators evolution
NOUVELLE PHARMACIE SERRIER

Sector positioning

Debt ratio
3151.83 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Watch +50 pts over 3 years

In 2024, the debt ratio of NOUVELLE PHARMACIE SERRIER (3151.83) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
2.58% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of NOUVELLE PHARMACIE SERRIER (2.6%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
-53.92 years 2023
2022
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Excellent

In 2023, the repayment capacity of NOUVELLE PHARMACIE SERRIER (-53.92) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 213.21. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

213.205

Liquidity indicators evolution
NOUVELLE PHARMACIE SERRIER

Sector positioning

Liquidity ratio
213.21 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good +41 pts over 3 years

In 2024, the liquidity ratio of NOUVELLE PHARMACIE SERRIER (213.21) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
209.06x 2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent

In 2023, the interest coverage of NOUVELLE PHARMACIE SERRIER (209.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
NOUVELLE PHARMACIE SERRIER

Positioning of NOUVELLE PHARMACIE SERRIER in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of NOUVELLE PHARMACIE SERRIER is estimated at 323 931 € (range 225 580€ - 484 619€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
225k€ 323k€ 484k€
323 931 € Range: 225 580€ - 484 619€
NAF 5 année 2024

Valuation method used

Net Income Multiple
23 203 € × 14.0x = 323 931 €
Range: 225 580€ - 484 619€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare NOUVELLE PHARMACIE SERRIER with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about NOUVELLE PHARMACIE SERRIER

What is the revenue of NOUVELLE PHARMACIE SERRIER ?

The revenue of NOUVELLE PHARMACIE SERRIER in 2023 is 6.6 M€.

Is NOUVELLE PHARMACIE SERRIER profitable?

Yes, NOUVELLE PHARMACIE SERRIER generated a net profit of 23 k€ in 2024.

Where is the headquarters of NOUVELLE PHARMACIE SERRIER ?

The headquarters of NOUVELLE PHARMACIE SERRIER is located in MONTIGNY-LES-METZ (57950), in the department Moselle.

Where to find the tax return of NOUVELLE PHARMACIE SERRIER ?

The tax return of NOUVELLE PHARMACIE SERRIER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does NOUVELLE PHARMACIE SERRIER operate?

NOUVELLE PHARMACIE SERRIER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.